MediBeacon transdermal GFR measurement system
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MediBeacon transdermal GFR measurement system, covering 2024-04-18 to 2024-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects [Phase 3]